Phibro Animal Health Financials - Benzinga

Phibro Animal Health Corp

PAHCNASDAQ

Trade with Public

Trade with Public

$36.70

1.083.03%

Last update: Sep 14, 9:32 AM

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Dividends Compare Options Stock Report

Phibro Animal Health Financials

Phibro Animal Health (PAHC) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Phibro Animal Health Sees FY2027 GAAP EPS $2.98-$3.22 vs $3.00 Est

Phibro Animal Health (NASDAQ:PAHC) is looking for FY2027 GAAP EPS of $2.98-$3.22 vs $3.00 analyst estimate..

Benzinga Newsdesk

PRO
Phibro Animal Health Sees FY2027 Adj EPS $3.41-$3.59 vs $3.34 Est; Sees Sales $1.550B-$1.600B vs $1.548B Est

Phibro Animal Health (NASDAQ:PAHC) is looking for FY2027 Adj EPS of $3.41-$3.59 vs $3.34 analyst estimate. sees sales of $1.550 billion-$1.600 billion vs $1.548 billion analyst estimate.

Benzinga Newsdesk

PRO
Phibro Animal Health Q4 Adj. EPS $0.85 Beats $0.71 Estimate, Sales $396.700M Beat $381.250M Estimate

Benzinga Newsdesk

Earnings Scheduled For May 6, 2026

Benzinga Insights

PRO
Phibro Animal Health Raises FY2026 GAAP EPS Guidance from $2.08-$2.32 to $2.25-$2.44 vs $2.53 Est

Benzinga Newsdesk

PRO
Phibro Animal Health Raises FY2026 Adj EPS Guidance from $2.93-$3.10 to $2.98-$3.10 vs $3.03 Est; Raises FY2026 Sales Guidance from $1.45B-$1.50B to $1.46B-$1.50B vs $1.488B Est

FISCAL YEAR 2026 FINANCIAL GUIDANCEOur updated fiscal year 2026 financial guidance is as shown below. Year-over-year percentages are calculated using the midpoint of the guidance ranges.Net sales of $1.46 billion to

Benzinga Newsdesk